Výsledky vyhledávání - Kathleen M. Darcy

Upřesnit hledání
  1. 1
    Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer

    Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer Autor Xijing He, Ahmet Arslan, Mark Pool, T-T Ho, Kathleen M. Darcy, John S. Coon, William T. Beck

    Vydáno 2010
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro

    Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro Autor Xijing He, Mark Pool, Kathleen M. Darcy, S B Lim, Nelly Auersperg, John S. Coon, William T. Beck

    Vydáno 2007
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Current Approaches and Challenges in Managing and Monitoring Treatment Response in Ovarian Cancer

    Current Approaches and Challenges in Managing and Monitoring Treatment Response in Ovarian Cancer Autor Charlotte Marcus, G. Larry Maxwell, Kathleen M. Darcy, Chad A. Hamilton, William P. McGuire

    Vydáno 2014
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  4. 4
    A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: A Gynecologic Oncology Group study

    A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: A Gynecologic Oncology Group study Autor D. Scott McMeekin, Michael W. Sill, Doris M. Benbrook, Kathleen M. Darcy, Deborah J. Stearns-Kurosawa, Lynne Eaton, S. Diane Yamada

    Vydáno 2007
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells

    Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells Autor Pang-ning Teng, Nicholas W. Bateman, Kathleen M. Darcy, Chad A. Hamilton, G. Larry Maxwell, Christopher J. Bakkenist, Thomas P. Conrads

    Vydáno 2015
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer

    Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving... Autor Gillian Thomas, Shamshad Ali, Frank Hoebers, Kathleen M. Darcy, William H. Rodgers, Malti Patel, O. Abulafia, Joseph A. Lucci, Adrian C. Begg

    Vydáno 2007
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Relationship Between<i>ERCC1</i>Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cisplatin and Paclitaxel for Stage III Epithelial Ovarian Cancer

    Relationship Between<i>ERCC1</i>Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cisplatin a... Autor Thomas C. Krivak, Kathleen M. Darcy, Chunqiao Tian, Deborah K. Armstrong, Bora Baysal, Holly H. Gallion, Christine B. Ambrosone, Julie A. DeLoia

    Vydáno 2008
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer

    High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer Autor Jennifer Veneris, Kathleen M. Darcy, Paulette Mhawech‐Fauceglia, Chunqiao Tian, Ernst Lengyel, Ricardo R. Lastra, Tanja Pejović, Suzanne D. Conzen, Gini F. Fleming

    Vydáno 2017
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Trends in Uterine Cancer Mortality in the United States

    Trends in Uterine Cancer Mortality in the United States Autor Sahana Somasegar, Aya Bashi, Susan M. Lang, Cheng-I Liao, C. A. Johnson, Kathleen M. Darcy, Chunqiao Tian, Daniel S. Kapp, John K. Chan

    Vydáno 2023
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study

    BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study Autor Jamie Lesnock, Kathleen M. Darcy, Chunqiao Tian, Julie A. DeLoia, Melissa M. Thrall, Chris Zahn, Deborah K. Armstrong, Michael J. Birrer, Thomas C. Krivak

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study

    Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study Autor Leslie M. Randall, Bradley J. Monk, Kathleen M. Darcy, Chunqiao Tian, Robert A. Burger, Shu‐Yuan Liao, William A. Peters, Richard J. Stock, John P. Fruehauf

    Vydáno 2008
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Phase II Study of Gefitinib in Patients with Relapsed or Persistent Ovarian or Primary Peritoneal Carcinoma and Evaluation of Epidermal Growth Factor Receptor Mutations and Immunohistochemical Expression: A Gynecologic Oncology Group Study

    Phase II Study of Gefitinib in Patients with Relapsed or Persistent Ovarian or Primary Peritoneal Carcinoma and Evaluation of Epidermal Growth Factor Receptor Mutations and Immunoh... Autor Russell J. Schilder, Michael W. Sill, Xiaowei Chen, Kathleen M. Darcy, Steven DeCesare, George Lewandowski, Roger B. Lee, Cletus Arciero, Hong Wu, Andrew K. Godwin

    Vydáno 2005
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A Gynecologic Oncology Group study

    Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary periton... Autor Kian Behbakht, Michael W. Sill, Kathleen M. Darcy, Stephen C. Rubin, Robert S. Mannel, Steven Waggoner, Russell J. Schilder, Kathy Q. Cai, Andrew K. Godwin, R. Katherine Alpaugh

    Vydáno 2011
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study

    Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study Autor Carol Aghajanian, Michael W. Sill, Kathleen M. Darcy, Benjamin E. Greer, D. Scott McMeekin, Peter G. Rose, Jacob Rotmensch, Mack N. Barnes, Parviz Hanjani, Kimberly K. Leslie

    Vydáno 2011
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study

    Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study Autor Shu‐Yuan Liao, Kathleen M. Darcy, Leslie M. Randall, Chunqiao Tian, Bradley J. Monk, Robert A. Burger, John P. Fruehauf, William A. Peters, Richard J. Stock, Eric J. Stanbridge

    Vydáno 2009
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study

    Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study Autor Gini F. Fleming, Michael W. Sill, Kathleen M. Darcy, D. Scott McMeekin, J.T. Thigpen, Lisa Adler, Jonathan S. Berek, Julia Chapman, Paul DiSilvestro, Ira Horowitz, James V. Fiorica

    Vydáno 2009
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study

    Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a compl... Autor Jean Hurteau, Mark F. Brady, Kathleen M. Darcy, William P. McGuire, Pamela Edmonds, Michael L. Pearl, I. I. Ivanov, Krishnansu S. Tewari, Robert S. Mannel, Kristine Zanotti, Doris M. Benbrook

    Vydáno 2010
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: A Gynecologic Oncology Group study

    Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: A Gynecolo... Autor Chunqiao Tian, Christine B. Ambrosone, Kathleen M. Darcy, Thomas C. Krivak, Deborah K. Armstrong, Michael A. Bookman, Warren Davis, Hua Zhao, Kirsten B. Moysich, Holly H. Gallion, Julie A. DeLoia

    Vydáno 2011
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer

    NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer Autor Neil T. Phippen, Nicholas W. Bateman, Guisong Wang, Kelly A. Conrads, Wei Ao, Pang-ning Teng, Tracy Litzi, Julie Oliver, G. Larry Maxwell, Chad A. Hamilton, Kathleen M. Darcy, Thomas P. Conrads

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: A Gynecologic Oncology Group study

    A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: A Gynecologic Oncology Group study Autor Kimberly K. Leslie, Michael W. Sill, Edgar Fischer, Kathleen M. Darcy, Robert S. Mannel, Krishnansu S. Tewari, Parviz Hanjani, Jason A. Wilken, Andre T. Baron, Andrew K. Godwin, Russell J. Schilder, Meenakshi Singh, Nita J. Maihle

    Vydáno 2013
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: